Scholarlink

Abstract <p><i>Mycoplasma pneumoniae</i> is a major pathogen causing community-acquired pneumonia, often co-infecting with other pathogens and leading to severe infections that are difficult to differentiate. Current diagnostic methods have significant limitations, including the inability to accurately distinguish <i>M. pneumoniae</i> from other pathogens and the lack of precise quantification. To address these issues, this study developed a TaqMan-based real-time quantitative PCR (TaqMan PCR) assay. Specific primers and probes were designed based on the 16S rRNA gene sequences of <i>M. pneumoniae</i> retrieved from GenBank. After optimization, the established assay provided a sensitive, accurate, reliable, and cost-effective platform for <i>M. pneumoniae</i> detection. A comparative analysis using clinically confirmed <i>M. pneumoniae</i> samples demonstrated a positivity rate of 97.5% with this method, outperforming the 90% positivity rate of commercially available diagnostic kits. Additionally, the quantification results of <i>M. pneumoniae</i> strains showed that the 1 : 10 passaged culture entered the logarithmic growth phase on days 4 and 5, followed by a sharp decline in cell numbers. These findings highlight the potential of the TaqMan PCR assay as an improved diagnostic tool for more effective clinical detection and monitoring of <i>M. pneumoniae</i> infections.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Development and Evaluation of a TaqMan Real-Time PCR Assay for the Detection of Mycoplasma pneumoniae

  • 期刊论文

  • 发表日期：

    2025年7月26日

查看全文
  • X. Yang,
  • K. Liang,
  • J. Yu,
  • H. Luo,
  • X. Su,
  • Z. Deng,
  • J. He

摘要

Abstract

Mycoplasma pneumoniae is a major pathogen causing community-acquired pneumonia, often co-infecting with other pathogens and leading to severe infections that are difficult to differentiate. Current diagnostic methods have significant limitations, including the inability to accurately distinguish M. pneumoniae from other pathogens and the lack of precise quantification. To address these issues, this study developed a TaqMan-based real-time quantitative PCR (TaqMan PCR) assay. Specific primers and probes were designed based on the 16S rRNA gene sequences of M. pneumoniae retrieved from GenBank. After optimization, the established assay provided a sensitive, accurate, reliable, and cost-effective platform for M. pneumoniae detection. A comparative analysis using clinically confirmed M. pneumoniae samples demonstrated a positivity rate of 97.5% with this method, outperforming the 90% positivity rate of commercially available diagnostic kits. Additionally, the quantification results of M. pneumoniae strains showed that the 1 : 10 passaged culture entered the logarithmic growth phase on days 4 and 5, followed by a sharp decline in cell numbers. These findings highlight the potential of the TaqMan PCR assay as an improved diagnostic tool for more effective clinical detection and monitoring of M. pneumoniae infections.